Antidepressant vortioxetine shows promise for treatment of Glioblastoma, suggests study Dr. Kamal Kant Kohli25 Sept 2024 10:30 PM ISTGlioblastoma is a particularly aggressive brain tumour that at present is incurable. Cancer doctors can extend patients' life expectancy through...
Desvenlafaxine, paroxetine, venlafaxine, and vortioxetine efficacious and acceptable in stable MDD Dr. Kamal Kant Kohli1 Nov 2022 8:00 PM ISTJAPAN: According to a study that was published in the Journal, Molecular Psychiatry, the antidepressants desvenlafaxine, paroxetine, venlafaxine, and...
Vortioxetine effective for treatment of major depressive disorders finds study Jacinthlyn Sylvia18 July 2022 11:00 AM ISTIn a new study published in Frontiers in Psychiatry, it was shown that vortioxetine is more effective in treating Major Depressive Disorder (MDD) in...
All doses of Vortioxetine may prevent relapse in patients with major depressive disorder Dr. Shravani Dali5 April 2022 9:00 AM ISTAll doses of vortioxetine are effective for relapse prevention, in patients with remitted major depressive disorder, according to a recent study...
Sun Pharma to market its own version of Vortioxetine, signs agreement with Lundbeck MD Bureau31 March 2022 12:02 PM ISTVortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder in adults.
